Le Lézard
Classified in: Transportation, Health
Subject: MAV

/R E P E A T -- Media Invitation - Important Announcement for Air Ambulance Evacuation/

MONTREAL, Oct. 2, 2017 /CNW Telbec/ - Airmedic and Skyservice Air Ambulance International, two names both pioneers in the ?eld of critical care air ambulance transport in Quebec, invite media representatives to attend a press conference announcing a new partnership which will strengthen the organization of emergency repatriations for the bene?t of an ever-increasing number of travellers.



Wednesday, October 4th at 10:00 AM


Skyservice Air Ambulance International

9785 Ryan Avenue,

Dorval, QC H9P-1A2


Sophie Larochelle, Executive Vice President, Airmedic
Sam Cimone, President Skyservice Air Ambulance International

RSVP by telephone or mail (see below for details).


SOURCE Airmedic

These press releases may also interest you

at 04:00
According to Acuity Market Intelligence, border authorities have embraced digital identification and biometric-based automation to simplify and accelerate border control processing. Acuity's latest report on border control kiosks reveals that 71...

at 04:00
Exscientia, the innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, is pleased to announce the appointment of Mr Alex Snow to its Board of Directors as Deputy Chairman. He brings significant strategic...

at 03:15
High Hampton Holdings Corp. ("High Hampton" or the "Company") is pleased to announce that its Board of Directors has appointed David E. Argudo as new Chief Executive Officer to the Company. Mr. Argudo has been an invaluable asset to the Company in...

at 03:00
Results published in Diabetes, Obesity and Metabolism    Newly published data from real-world European clinical practice has shown that Xultophy® (insulin degludec/liraglutide) significantly reduced blood sugar levels in people with type 2 diabetes...

at 03:00
MedShr was commended at the Startups Awards in the Founders Pledge Social Impact and App of the Year categories   MedShr - The App for Doctors - has been Highly Commended in the Founders Pledge Social Impact Award and Commended in the App of the...

at 02:00
Kyowa Hakko Kirin Co., Ltd. (Tokyo: 4151, President and CEO: Nobuo Hanai, "Kyowa Hakko Kirin") announced today that the results of the Global Phase 3 study (MAVORIC: Mogamulizumab anti-CCR4 Antibody Versus ComparatOR In CTCL) investigating the use of...

News published on 4 october 2017 at 06:00 and distributed by: